Cargando…

Role of the Epigenetic Modifier JMJD6 in Tumor Development and Regulation of Immune Response

JMJD6 is a member of the Jumonji (JMJC) domain family of histone demethylases that contributes to catalyzing the demethylation of H3R2me2 and/or H4R3me2 and regulating the expression of specific genes. JMJD6-mediated demethylation modifications are involved in the regulation of transcription, chroma...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Kai, Yang, Chao, Li, Haibin, Liu, Xiaoyan, Zheng, Meiling, Xuan, Zixue, Mei, Zhiqiang, Wang, Haiyong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8963961/ https://www.ncbi.nlm.nih.gov/pubmed/35359945 http://dx.doi.org/10.3389/fimmu.2022.859893

Ejemplares similares

Immunomodulatory role of metalloproteinase ADAM17 in tumor development
por: Wang, Kai, et al.
Publicado: (2022)

Histone demethylase JMJD2C: epigenetic regulators in tumors
por: Zhang, Chengcheng, et al.
Publicado: (2017)

The epigenetic modifier JMJD6 is amplified in mammary tumors and cooperates with c-Myc to enhance cellular transformation, tumor progression, and metastasis
por: Aprelikova, Olga, et al.
Publicado: (2016)

Editorial: Studying novel immune signatures, targets, and drugs in hepatobiliary tumors: based on advanced technologies
por: Xuan, Zixue, et al.
Publicado: (2023)

The JMJD Family Histone Demethylases in Crosstalk Between Inflammation and Cancer
por: Yang, Jia, et al.
Publicado: (2022)

Augmenting Antitumor Immune Responses with Epigenetic Modifying Agents
por: Héninger, Erika, et al.
Publicado: (2015)

Epigenome screening highlights that JMJD6 confers an epigenetic vulnerability and mediates sunitinib sensitivity in renal cell carcinoma
por: Zhang, Chuanjie, et al.
Publicado: (2021)

Role of Epigenetic Regulation in Plasticity of Tumor Immune Microenvironment
por: Yang, Yunkai, et al.
Publicado: (2021)

Active ingredients of traditional Chinese medicine for enhancing the effect of tumor immunotherapy
por: Yang, Chao, et al.
Publicado: (2023)

The Novel Protease Activities of JMJD5–JMJD6–JMJD7 and Arginine Methylation Activities of Arginine Methyltransferases Are Likely Coupled
por: Liu, Haolin, et al.
Publicado: (2022)

Role of JMJD6 in Breast Tumourigenesis
por: Poulard, Coralie, et al.
Publicado: (2015)

Impact of JMJD6 on intrahepatic cholangiocarcinoma
por: Kosai-Fujimoto, Yukiko, et al.
Publicado: (2022)

The impact of microbially modified metabolites associated with obesity and bariatric surgery on antitumor immunity
por: Wang, Meng, et al.
Publicado: (2023)

Epigenetic and Immune-Cell Infiltration Changes in the Tumor Microenvironment in Hepatocellular Carcinoma
por: Wu, Zeng-Hong, et al.
Publicado: (2021)

Specific Recognition of Arginine Methylated Histone Tails by JMJD5 and JMJD7
por: Liu, Haolin, et al.
Publicado: (2018)

Epigenetic Control of Autophagy Related Genes Transcription in Pulpitis via JMJD3
por: Yin, Bei, et al.
Publicado: (2021)

The N(6)-Methyladenosine-Modified Pseudogene HSPA7 Correlates With the Tumor Microenvironment and Predicts the Response to Immune Checkpoint Therapy in Glioblastoma
por: Zhao, Rongrong, et al.
Publicado: (2021)

JMJD3: a critical epigenetic regulator in stem cell fate
por: Ding, Yuanjie, et al.
Publicado: (2021)

Inhibition of JMJD6 by 2‐Oxoglutarate Mimics
por: Islam, Md. Sailful, et al.
Publicado: (2021)

Global gene expression profiling of JMJD6- and JMJD4-depleted mouse NIH3T3 fibroblasts
por: Hu, Yu-Jie, et al.
Publicado: (2016)

Regulation of Epigenetic Modifiers, Including KDM6B, by Interferon-γ and Interleukin-4 in Human Macrophages
por: Yıldırım-Buharalıoğlu, Gökçe, et al.
Publicado: (2017)

Editorial: Epigenetics of the immune component of inflammation
por: Liu, Yan-Jun, et al.
Publicado: (2022)

JMJD1C Exhibits Multiple Functions in Epigenetic Regulation during Spermatogenesis
por: Nakajima, Ryusuke, et al.
Publicado: (2016)

JMJD8 Is an M2 Macrophage Biomarker, and It Associates With DNA Damage Repair to Facilitate Stemness Maintenance, Chemoresistance, and Immunosuppression in Pan-Cancer
por: Liang, Xisong, et al.
Publicado: (2022)

Epigenetic Regulation of NK Cell-Mediated Antitumor Immunity
por: Xia, Miaoran, et al.
Publicado: (2021)

JMJD3 promotes esophageal squamous cell carcinoma pathogenesis through epigenetic regulation of MYC
por: Li, Shu-Man, et al.
Publicado: (2020)

JMJD6 Regulates ERα Methylation on Arginine
por: Poulard, Coralie, et al.
Publicado: (2014)

Epigenetic Modifiers: Anti-Neoplastic Drugs With Immunomodulating Potential
por: Maes, Ken, et al.
Publicado: (2021)

JMJD6 and U2AF65 co-regulate alternative splicing in both JMJD6 enzymatic activity dependent and independent manner
por: Yi, Jia, et al.
Publicado: (2017)

Jmjd3/IRF4 axis aggravates myeloid fibroblast activation and m2 macrophage to myofibroblast transition in renal fibrosis
por: Liang, Hua, et al.
Publicado: (2022)

Control of enhancer and promoter activation in the type I interferon response by the histone demethylase Kdm4d/JMJD2d
por: Chandwani, Rohit, et al.
Publicado: (2023)

The Role of m6A Epigenetic Modification in the Treatment of Colorectal Cancer Immune Checkpoint Inhibitors
por: Tong, Huan, et al.
Publicado: (2022)

Metabolites in the Tumor Microenvironment Reprogram Functions of Immune Effector Cells Through Epigenetic Modifications
por: Li, Yijia, et al.
Publicado: (2021)

Epigenetic modulation and prostate cancer: Paving the way for NK cell anti-tumor immunity
por: dos Reis, Filipa D., et al.
Publicado: (2023)

JMJD6 is a tumorigenic factor and therapeutic target in neuroblastoma
por: Wong, Matthew, et al.
Publicado: (2019)

Effect of dietary soybean saponin Bb on the growth performance, intestinal nutrient absorption, morphology, microbiota, and immune response in juvenile Chinese soft-shelled turtle (Pelodiscus sinensis)
por: Wang, Yue, et al.
Publicado: (2022)

Editorial: Epigenetic Regulation of Innate Immunity
por: de Winther, Menno P. J., et al.
Publicado: (2021)

Epigenetics Regulates Antitumor Immunity in Melanoma
por: Chen, Yuhan, et al.
Publicado: (2022)

Epigenetic silencing of JMJD5 promotes the proliferation of hepatocellular carcinoma cells by down-regulating the transcription of CDKN1A
por: Wu, Bing-Hao, et al.
Publicado: (2016)

JMJD6 Promotes Colon Carcinogenesis through Negative Regulation of p53 by Hydroxylation
por: Wang, Feng, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_m3pek3jitc3nnt06d6nc3lgdut